Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells.
about
PI3K: An Attractive Candidate for the Central Integration of Metabolism and ReproductionThe Deep Correlation between Energy Metabolism and Reproduction: A View on the Effects of Nutrition for Women FertilityFunctional genomics of PCOS: from GWAS to molecular mechanismsStimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cellsRegulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cellsObesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cellInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Uncovering steroidopathy in women with autism: a latent class analysisFetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys.Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertilityState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Reproductive tissues maintain insulin sensitivity in diet-induced obesity.The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate CancerCommentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesisFetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.Nonhuman primates as models for human adrenal androgen production: function and dysfunction.Menstrual health and the metabolic syndrome in adolescents.Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line.Insulin and hyperandrogenism in women with polycystic ovary syndrome.A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndromeFemale adipocyte androgen synthesis and the effects of insulinTargeting insulin sensitivity in the treatment of polycystic ovary syndrome.Current perspectives of insulin resistance and polycystic ovary syndrome.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Effect of Citrullus colocynthis hydro-alcoholic extract on hormonal and folliculogenesis process in estradiol valerate-induced PCOs rats model: An experimental study.Insulin signaling displayed a differential tissue specific response to low dose DHT in female mice.IGF1R Expression in Ovarian Granulosa Cells Is Essential for Steroidogenesis, Follicle Survival, and Fertility in Female Mice.Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.Peripubertal hyperinsulinemia upregulates phosphatidylinositol 3-kinase/akt pathway in rat ovaries.Inhibition of cytochrome P-450 C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats.Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review
P2860
Q21131282-D88BC973-76B9-4F1D-A99C-9B66C36B5EF4Q26766160-A62498AA-5B24-4D8C-8E8D-A9BC8536403DQ28083015-BD799BFA-B96E-47D5-9EAC-FF78E56B6225Q28567265-D081DB05-E669-4FEF-9E67-1DDC36A1611AQ28583064-628E5343-E0D1-4337-ACB7-9CE9FE7208A9Q30406039-D5FF417C-D359-4DE0-9935-6E054F8779E9Q33569169-89957C12-5DBD-4F7C-9B7D-9F10D555EBB0Q33616148-BE957203-17C5-49F1-90FF-869C09DEF071Q34047348-301976C4-92D4-4BC4-8C07-2F7FED2D6C45Q35053302-4C75A782-E496-48D4-B7F2-462CCDFA17C1Q35233754-B47AD79D-BA14-4B44-B802-4B5FDB1F8045Q35612399-A3059125-0B52-4459-8D7C-17F430830BA3Q35882782-7B23C785-D774-48B7-8E12-FD1CB027E642Q36303511-DB9C3061-26C9-4B5D-9E1B-B5EBF637473AQ36578772-25161D01-2D29-41F3-96EA-4B4E72741C9CQ36865817-B070AED4-4767-4873-B32A-4837525B3129Q37071255-D7A5ECE9-5298-4CF4-8421-C099526E3D9AQ37106561-646F5B96-696F-43DE-8585-A31459F1683DQ37122965-68E30B81-EBD3-456A-904B-078C5695819DQ37198401-C039075D-9B40-45E4-BC65-A27A4546C1C3Q37326696-51EE76E4-E9AE-48EB-ADD2-50E9049F06C9Q37355746-8FA0F1F1-E133-419D-94A6-149AABCAC3E8Q37391048-E7EC0773-3905-4DFC-8959-3833D0C5BBB6Q37434161-4B129E23-B57C-49C9-A988-5D675FCF4050Q37570577-2EC141BE-2D18-45B7-AF1B-BF937591C627Q37939291-53509166-B4D8-4EC0-8898-0FBCACD0DD99Q38861206-12C442CE-7D0F-4C3B-B879-569FC433CFF3Q40737068-E36127DF-1C34-45CB-9D4D-4331B7893545Q41640666-CA2F4294-DF27-4844-8025-9FAED80FEF63Q47547532-B535360E-4434-4960-9636-7364A3981363Q47551210-14B79880-7580-4DAE-868B-4253E22873DAQ47794618-B74B534E-1DB2-47EE-AE49-A85F36345BC2Q50972532-C7EE1870-E81B-4579-83C0-BDCAF3414627Q51517628-91CBF713-C589-482E-9F5D-488020BFE423Q51705963-A6AAB41D-3B5E-4AC1-8DDD-A9C008C67251Q51755030-84481AE8-4944-40F9-9CD8-53DD5EB706F5Q51771105-3FE26C27-F5BD-4897-987B-EB9F615981ACQ55403020-A76F0E4F-984D-4001-AA50-D8D8112E869AQ57473711-612F6C81-E063-4AD0-ADA7-0C5110BD049D
P2860
Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@ast
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@en
type
label
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@ast
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@en
prefLabel
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@ast
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@en
P2093
P356
P1433
P1476
Insulin augmentation of 17alph ...... in human ovarian theca cells.
@en
P2093
David H Geller
Denis A Magoffin
Donna Torbati
Hui-Wen Yen
Iqbal Munir
Rebecca M Bierden
Sanjay K Agarwal
Stacy R Weitsman
P304
P356
10.1210/EN.2003-0329
P407
P577
2003-09-25T00:00:00Z